Status
Conditions
Treatments
About
Efficiency and safety of high-frequency radio wave electrotherapy with a radio frequency of 448 kHz in the treatment of patients with organic erectile dysfunction. Sham comparator, parallel study including both the main and control group to demonstrate the efficiency of the device to treat erectile dysfunction.
Full description
The objectives of this study are:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Non-inclusion criteria:
The use of other treatments for erectile dysfunction
Age under 18 and over 79 years old;
Anatomical deformation of the penis (angulation, cavernous fibrosis or Peyronie's disease);
The presence of diseases predisposing to the development of priapism (sickle cell anemia, multiple myeloma, leukemia, thrombocytopenia);
Running coagulation disorders;
The presence of tumors in the area of electrotherapy;
The presence of aneurysms in the propagation of radio frequency waves;
Angina pectoris;
Myocardial infarction, stroke, life-threatening arrhythmias;
Thrombosis, thromboembolic disease;
Arterial hypertension (blood pressure ≥ 170/90 mm Hg) or hypotension (blood pressure ≤ 90/50 mm Hg.);
The patient has a mental illness that does not allow an assessment of the effectiveness of therapy; history of alcoholism and drug addiction;
Active tuberculosis, chronic somatic diseases in the acute stage; 15. Condition after coronary artery bypass grafting (CABG); 16. Patient's involvement in another clinical trial in the last 3 months;
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
60 participants in 2 patient groups
Loading...
Central trial contact
Dmitry Korolev, M.D.; Dmitry Enikeev, M.D., Ph.D.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal